论文信息 - [18F]p-MPPF: A Radiolabeled Antagonist for the Study of 5-HT1A Receptors with PET - 字舞流文

[18F]p-MPPF: A Radiolabeled Antagonist for the Study of 5-HT1A Receptors with PET

André Luxen | Christian Degueldre | Pierre Maquet | Eric Salmon | William P. Melega | Alain Plenevaux | Philippe Damhaut | Goran Lacan | Sonia Fuchs | C. Brihaye | Christian Lemaire | Steven Laureys | Joël Aerts | C. Degueldre | A. Luxen | P. Maquet | S. Fuchs | J. Aerts | E. Salmon | C. Lemaire | A. Plenevaux | J. Pujol | P. Damhaut | S. Laureys | D. Bars | D. Rubins | W. Melega | Daniel Rubins | Dinah Weissmann | D. Le Bars | Jean Francois Pujol | C. Brihaye | G. Lacan | D. Weissmann

[1] D. Le Bars,et al. In vivo characterization of p‐[18F]MPPF, a fluoro analog of WAY‐100635 for visualization of 5‐HT1a receptors , 2000, Synapse.

[2] A. Luxen,et al. Solid phase extraction : An alternative to the use of rotary evaporators for solvent removal in the rapid formulation of PET radiopharmaceuticals , 1999 .

[3] C. Degueldre,et al. 5-HT1A receptor distribution in the human brain: preliminary PET data with p-[18F]MPPF. , 1999 .

[4] C. Degueldre,et al. 5-HT1A Receptors visualization with p-[18F]MPPF in healthy volunteers. , 1999 .

[5] D Comar,et al. High-yield radiosynthesis and preliminary in vivo evaluation of p-[18F]MPPF, a fluoro analog of WAY-100635. , 1998, Nuclear medicine and biology.

[6] B. Jacobs,et al. Effects of Sleep Deprivation on Serotonergic Neuronal Activity in the Dorsal Raphe Nucleus of the Freely Moving Cat , 1997, Neuropsychopharmacology.

[7] S. Stahl,et al. Human sleep EEG following the 5-HT1A antagonist pindolol: possible disinhibition of raphe neuron activity , 1997, Brain Research.

[8] A. Meneses,et al. Role of 5‐HT1A Receptors in Acquisition, Consolidation and Retrieval of Learning , 1997 .

[9] H. Kung,et al. p‐[18F]‐MPPF: A potential radioligand for PET studies of 5‐HT1A receptors in humans , 1997, Synapse.

[10] A. Luxen,et al. Evaluation of p-[F-18]MPPF, 5-HT1A antagonist, in rats: tissue distribution, autoradiography and metabolism. , 1997 .

[11] S. Cherry,et al. MicroPET: a high resolution PET scanner for imaging small animals , 1996, 1996 IEEE Nuclear Science Symposium. Conference Record.

[12] H. Kung,et al. Short Communication New 5‐HT1A receptor antagonist: [3H]p‐MPPF , 1996, Synapse.

[13] A Frazer,et al. 4-(2'-Methoxyphenyl)-1-[2'-[N-(2"-pyridinyl)-p-iodobenzamido]ethyl] piperazine and 4-(2'-methoxyphenyl)-1-[2'-[N-(2"-pyridinyl)-p- fluorobenzamido]ethyl]piperazine, two new antagonists at pre- and postsynaptic serotonin-1A receptors. , 1996, The Journal of pharmacology and experimental therapeutics.

[14] S. Peroutka. Serotonin Receptor Subtypes , 1995 .

[15] P R Saxena,et al. Serotonin receptors: subtypes, functional responses and therapeutic relevance. , 1995, Pharmacology & therapeutics.

[16] R. Hen,et al. 5-Hydroxytryptamine receptor subtypes in vertebrates and invertebrates , 1994, Neurochemistry International.

[17] H. Kung,et al. Synthesis and evaluation of 4-(2'-methoxyphenyl)-1-[2'-[N-(2"-pyridinyl)-p- iodobenzamido]ethyl]piperazine (p-MPPI): a new iodinated 5-HT1A ligand. , 1994, Journal of medicinal chemistry.

[18] N. Andén,et al. (S)-5-fluoro-8-hydroxy-2-(dipropylamino)tetralin: a putative 5-HT1A-receptor antagonist. , 1990, Journal of medicinal chemistry.

[19] R. Glennon. Serotonin receptors: Clinical implications , 1990, Neuroscience & Biobehavioral Reviews.